• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像评估肝纤维化、脂肪和铁与超声评估纤维化和脂肪:放射科医师实用指南。

Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists.

机构信息

From the Department of Radiology, Thomas Jefferson University, 132 S 10th St, Philadelphia, PA 19107 (F.F.G.); Department of Radiology, Northeastern Ohio Medical University, Rootstown, Ohio (R.G.B.); Department of Radiology and Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Tex (T.Y.); Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy (G.F.); Department of Radiology, University of Kentucky, Lexington, Ky (J.T.L.); Department of Radiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio (J.R.D.); Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Ill (J.M.H., F.H.M.); Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, Ontario, Canada (K.S.J.); Department of Radiology, ChristianaCare, Newark, Del (R.Y.M.); Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (A.M.); Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, Calif (M.A.O., B.M.Y.); Departments of Radiology and Medical Physics (A.P.) and Departments of Radiology, Medical Physics, Biomedical Engineering, Medicine, and Emergency Medicine (S.B.R.), University of Wisconsin, Madison, Wis; Department of Radiology, NYU Langone Health, New York, NY (K.S.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (A.C.S.); Department of Radiology, University of Alabama at Birmingham, Birmingham, Ala (E.N.S.); Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, Tex (V.R.S.); Department of Diagnostic, Molecular and Interventional Radiology, BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY (B.T.); and Department of Radiology, Mayo Clinic, Rochester, Minn (C.L.W., S.K.V.).

出版信息

Radiographics. 2023 Jun;43(6):e220181. doi: 10.1148/rg.220181.

DOI:10.1148/rg.220181
PMID:37227944
Abstract

Quantitative imaging biomarkers of liver disease measured by using MRI and US are emerging as important clinical tools in the management of patients with chronic liver disease (CLD). Because of their high accuracy and noninvasive nature, in many cases, these techniques have replaced liver biopsy for the diagnosis, quantitative staging, and treatment monitoring of patients with CLD. The most commonly evaluated imaging biomarkers are surrogates for liver fibrosis, fat, and iron. MR elastography is now routinely performed to evaluate for liver fibrosis and typically combined with MRI-based liver fat and iron quantification to exclude or grade hepatic steatosis and iron overload, respectively. US elastography is also widely performed to evaluate for liver fibrosis and has the advantage of lower equipment cost and greater availability compared with those of MRI. Emerging US fat quantification methods can be performed along with US elastography. The author group, consisting of members of the Society of Abdominal Radiology (SAR) Liver Fibrosis Disease-Focused Panel (DFP), the SAR Hepatic Iron Overload DFP, and the European Society of Radiology, review the basics of liver fibrosis, fat, and iron quantification with MRI and liver fibrosis and fat quantification with US. The authors cover technical requirements, typical case display, quality control and proper measurement technique and case interpretation guidelines, pitfalls, and confounding factors. The authors aim to provide a practical guide for radiologists interpreting these examinations. RSNA, 2023 See the invited commentary by Ronot in this issue.

摘要

MRI 和 US 测量的肝脏疾病定量成像生物标志物正在成为慢性肝病 (CLD) 患者管理中的重要临床工具。由于其准确性高且为非侵入性,在许多情况下,这些技术已取代肝活检,用于 CLD 患者的诊断、定量分期和治疗监测。最常评估的成像生物标志物是肝纤维化、脂肪和铁的替代物。磁共振弹性成像现在通常用于评估肝纤维化,并且通常与基于 MRI 的肝脂肪和铁定量相结合,以分别排除或分级肝脂肪变性和铁过载。超声弹性成像也广泛用于评估肝纤维化,与 MRI 相比,它具有设备成本更低和可用性更高的优势。新兴的超声脂肪定量方法可以与超声弹性成像同时进行。由腹部放射学会 (SAR) 肝纤维化疾病重点小组 (DFP)、SAR 肝铁过载 DFP 和欧洲放射学会的成员组成的作者小组,回顾了 MRI 测量肝纤维化、脂肪和铁以及 US 测量肝纤维化和脂肪的基础知识。作者涵盖了技术要求、典型病例展示、质量控制以及适当的测量技术和病例解释指南、陷阱和混杂因素。作者旨在为解释这些检查的放射科医生提供实用指南。RSNA,2023 请参阅本期 Ronot 的特邀评论。

相似文献

1
Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists.磁共振成像评估肝纤维化、脂肪和铁与超声评估纤维化和脂肪:放射科医师实用指南。
Radiographics. 2023 Jun;43(6):e220181. doi: 10.1148/rg.220181.
2
Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver "Triple Screen".肝脏脂肪、铁和纤维化的多参数磁共振评估:肝脏“三联筛查”简明概述
Abdom Radiol (NY). 2023 Jun;48(6):2060-2073. doi: 10.1007/s00261-023-03887-0. Epub 2023 Apr 11.
3
Magnetic Resonance Imaging of Liver Fibrosis, Fat, and Iron.肝脏纤维化、脂肪和铁的磁共振成像。
Radiol Clin North Am. 2022 Sep;60(5):705-716. doi: 10.1016/j.rcl.2022.04.003. Epub 2022 Jul 15.
4
Can MR elastography be used to measure liver stiffness in patients with iron overload?磁共振弹性成像能否用于测量铁过载患者的肝硬度?
Abdom Radiol (NY). 2019 Jan;44(1):104-109. doi: 10.1007/s00261-018-1723-9.
5
Liver fibrosis: Review of current imaging and MRI quantification techniques.肝纤维化:当前影像学及磁共振成像定量技术综述
J Magn Reson Imaging. 2017 May;45(5):1276-1295. doi: 10.1002/jmri.25550. Epub 2016 Dec 16.
6
Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes.磁共振弹性成像技术在肝纤维化分期中的应用:慢性乙型肝炎与其他病因患者的诊断性能比较。
Radiology. 2016 Jul;280(1):88-97. doi: 10.1148/radiol.2016150397. Epub 2016 Feb 4.
7
Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.利用 MRI 对弥漫性肝病进行肝脂肪变性和铁过载的准确同步定量分析。
Abdom Radiol (NY). 2017 May;42(5):1434-1443. doi: 10.1007/s00261-017-1048-0.
8
Liver MR Elastography Technique and Image Interpretation: Pearls and Pitfalls.肝脏磁共振弹性成像技术及图像解读:要点与难点。
Radiographics. 2019 Nov-Dec;39(7):1983-2002. doi: 10.1148/rg.2019190034. Epub 2019 Oct 18.
9
Updates on Quantitative MRI of Diffuse Liver Disease: A Narrative Review.漫谈肝脏弥散性疾病的定量 MRI 研究进展
Biomed Res Int. 2022 Dec 28;2022:1147111. doi: 10.1155/2022/1147111. eCollection 2022.
10
Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound.囊性纤维化定量肝脏磁共振成像的前瞻性研究:可行性及与PUSH队列超声检查的比较
Pediatr Radiol. 2023 Oct;53(11):2210-2220. doi: 10.1007/s00247-023-05706-6. Epub 2023 Jul 28.

引用本文的文献

1
Best practices for pediatric liver MRI: guidelines from members of the Society for Pediatric Radiology Magnetic Resonance and Abdominal Imaging Committees.小儿肝脏磁共振成像的最佳实践:来自儿科放射学会磁共振和腹部成像委员会成员的指南
Pediatr Radiol. 2025 Sep 10. doi: 10.1007/s00247-025-06383-3.
2
Optimization of measurements with an ultrasound attenuation coefficient algorithm for quantifying liver fat.使用超声衰减系数算法对肝脏脂肪定量测量的优化。
Eur Radiol. 2025 Sep 5. doi: 10.1007/s00330-025-11906-5.
3
Hepatocyte uptake ratio derived from T1 mapping for quantitative assessment of liver fibrosis.
基于T1映射的肝细胞摄取率用于肝纤维化的定量评估。
Eur Radiol. 2025 Jul 30. doi: 10.1007/s00330-025-11842-4.
4
MRI findings of confluent hepatic fibrosis caused by different etiologies.不同病因所致融合性肝纤维化的磁共振成像表现
BMC Gastroenterol. 2025 Jul 10;25(1):512. doi: 10.1186/s12876-025-04101-9.
5
Diagnostics: Markers of Body Iron Status.诊断:机体铁状态标志物。
Adv Exp Med Biol. 2025;1480:387-398. doi: 10.1007/978-3-031-92033-2_25.
6
Towards MRI Study of Biointegration of Carbon-Carbon Composites with Ca-P Coatings.关于碳-碳复合材料与钙磷涂层生物整合的磁共振成像研究
Nanomaterials (Basel). 2025 Mar 26;15(7):492. doi: 10.3390/nano15070492.
7
Concordance of vibration-controlled transient elastography and magnetic resonance elastography for fibrosis staging in patients with metabolic dysfunction-associated steatotic liver disease.振动控制瞬时弹性成像与磁共振弹性成像在代谢功能障碍相关脂肪性肝病患者纤维化分期中的一致性
Eur Radiol. 2025 Mar 30. doi: 10.1007/s00330-025-11533-0.
8
Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy.前沿:铁死亡在代谢功能障碍相关脂肪性肝病(MASLD)发病机制及治疗中的作用
Funct Integr Genomics. 2025 Mar 25;25(1):71. doi: 10.1007/s10142-025-01579-0.
9
Comparison of MRI and CT based deep learning radiomics analyses and their combination for diagnosing intrahepatic cholangiocarcinoma.基于MRI和CT的深度学习放射组学分析及其联合用于诊断肝内胆管癌的比较
Sci Rep. 2025 Mar 20;15(1):9629. doi: 10.1038/s41598-025-92263-7.
10
MR and Ultrasound for Liver Fat Assessment in Children: Techniques and Supporting Evidence.用于儿童肝脏脂肪评估的磁共振成像和超声检查:技术与支持证据
J Magn Reson Imaging. 2025 Sep;62(3):691-706. doi: 10.1002/jmri.29756. Epub 2025 Mar 5.